Incidence of Pancreatic Fistula After Radical Gastrectomy
- Conditions
- Pancreatic FistulaComplicationGastric Cancer
- Interventions
- Diagnostic Test: Amylase Test
- Registration Number
- NCT03391687
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Brief Summary
This study is designed to investigate the incidence of pancreatic fistula after radical gastrectomy in gastric cancer patients.
- Detailed Description
Pancreatic fistula, which can lead to fatal end, is one of the most serious complications after radical gastrectomy. It is usually treated as a key factor to evaluate the quality of gastrectomy. The incidence of pancreatic fistula is far different between different areas, knowing the prevalence of pancreatic fistula and risk factors can help us to prevent pancreatic fistula and improve the short time outcome of gastric cancer surgery treatment. So, we designed this perspective, multi-center study to investigate the incidence of pancreatic fistula and its outcome in China.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2100
- pathological confirmed stomach adenocarcinoma
- preoperative curatively resectable tumor
- pancreas resection
- emergent surgery due to gastric cancer acute complications
- cancer of gastric remnant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Amylase Test Amylase Test gastric cancer patients receiving radical gastrectomy
- Primary Outcome Measures
Name Time Method Incidence of Pancreatic Fistula in 30 days following gastrectomy the incidence of pancreatic fistula after radical gastrectomy in gastric cancer patients
- Secondary Outcome Measures
Name Time Method The Classification of Pancreatic Fistula in 30 days following gastrectomy the percentage of different grades of pancreatic fistula, including Grade BL, Grade B and Grade C
The mortality of Grade B and C Pancreatic Fistula in 30 days following gastrectomy the percentage of patients died of Grade B or C pancreatic fistula
Trial Locations
- Locations (20)
Beijing Cancer Hospital
π¨π³Beijing, Beijing, China
ZhongShan hospital Fudan university
π¨π³Shanghai, Shanghai, China
Fujian Medical University Union Hospital
π¨π³Fuzhou, Fujian, China
Beijing Chao-Yang Hospital
π¨π³Beijing, Beijing, China
Henan Cancer Hospital
π¨π³Zhengzhou, Henan, China
Weifang People's Hospital
π¨π³Weifang, Shandong, China
South West Hospital
π¨π³Chongqing, Chongqing, China
Guangdong General Hospital
π¨π³Guangzhou, Guangdong, China
The First Affiliated Hospital, Sun Yat-sen University
π¨π³Guangzhou, Guangdong, China
Jiangsu Province Hospital
π¨π³Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanchang University
π¨π³Nanchang, Jiangxi, China
The Second Hospital of Jilin University
π¨π³Changchun, Jilin, China
Renji Hospital, Shanghai Jiaotong University
π¨π³Shanghai, Shanghai, China
Affiliated Hospital of Qinghai University
π¨π³Xining, Qinghai, China
The First Affiliated Hospital of Xi'an Jiaotong University
π¨π³Xi'an, Shanxi, China
Ruijing Hospital, Shanghai Jiaotong University
π¨π³Shanghai, Shanghai, China
The First Affiliated Hospital of Xinjiang Medical University
π¨π³ΓrΓΌmqi, Xinjiang, China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicince
π¨π³Hangzhou, Zhejiang, China
Hangzhou First People's Hospital
π¨π³Hangzhou, Zhejiang, China
Fujian Cancer Hospital
π¨π³Fuzhou, Fujian, China